RELIEF THERAPEUTICS Holdings A
EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): AGMEGM
Relief Announces Results of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG Approved with Large Majority
18.12.2020 / 07:00
RELIEF THERAPEUTICS Holding AG Approved with Large Majority
Geneva, Switzerland, December 18, 2020 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) (
Relief or the
Company ), a biopharmaceutical company with its lead compound RLF-100
TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, announces that all agenda items of yesterday s Extraordinary General Meeting (
EGM ) were approved with a large majority (more than 90 percent) of the represented votes.
As a result of the exceptional circumstances due to the coronavirus pandemic, the EGM was held without the physical presence of shareholders, representatives and third parties in accordance with the requirements of the Ordinance of the Swiss F
EQS-News: RELIEF THERAPEUTICS Holdings AG: Relief gibt die Ergebnisse der mit großer Mehrheit angenommenen Tagesordnungspunkte der außerordentlichen Hauptversammlung der RELIEF THERAPEUTICS Holding AG bekannt finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
12/18/2020 | Press release | Distributed by Public on 12/18/2020 00:05
Relief Announces Results of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG Approved with Large Majority
Geneva, Switzerland, December 18, 2020 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ( Relief or the Company ), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, announces that all agenda items of yesterday s Extraordinary General Meeting ( EGM ) were approved with a large majority (more than 90 percent) of the represented votes.
As a result of the exceptional circumstances due to the coronavirus pandemic, the EGM was held without the physical presence of shareholders, representatives and third parties in accordance with the requirements of the Ordinance of the Swiss Federal Council regarding measures on combatting the coronavirus. 1,712 shareholders voted through the independent proxy, re